# Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
Canonical URL: https://biopharmsignal.com/news/FLGT/fulgent-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-friday-february-27-2026
Ticker: FLGT
Company: Fulgent Genetics, Inc.
Source: Fulgent Genetics, Inc.
Published: 2026-02-12 12:30 EST
Original Source URL: https://ir.fulgentgenetics.com
## Summary

EL MONTE, Calif. --(BUSINESS WIRE)--Feb. 12, 2026-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its fourth quarter and

## Article Body
EL MONTE, Calif. --(BUSINESS WIRE)--Feb. 12, 2026-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its fourth quarter and
## Recent Company News
- 2026-06-01 23:00 EST — [Fulgent Presents Updated FID-007 Data at ASCO 2026](https://biopharmsignal.com/news/FLGT/fulgent-presents-updated-fid-007-data-at-asco-2026) — Source: Fulgent Genetics, Inc.
- 2026-05-21 21:03 EST — [Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting](https://biopharmsignal.com/news/FLGT/fulgent-announces-rapid-oral-full-abstract-publication-for-fid-007-within-the-head-and-neck-cancer-track-session-at-the-asco-2026-annual-meeting) — Source: Fulgent Genetics, Inc.
- 2026-05-01 11:00 EST — [Fulgent Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/FLGT/fulgent-reports-first-quarter-2026-financial-results) — Source: Fulgent Genetics, Inc.
- 2026-04-22 20:05 EST — [Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting](https://biopharmsignal.com/news/FLGT/fulgent-selected-to-present-rapid-oral-abstract-within-the-head-and-neck-cancer-track-session-at-the-2026-asco-annual-meeting) — Source: Fulgent Genetics, Inc.
- 2026-04-16 11:30 EST — [Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026](https://biopharmsignal.com/news/FLGT/fulgent-to-announce-first-quarter-2026-financial-results-on-friday-may-1-2026) — Source: Fulgent Genetics, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)